biocon biologics meets the billion dollar commitment: shreehas tambe, ceo & md, biocon biologics
Published 5 months ago • 631 plays • Length 7:57Download video MP4
Download video MP3
Similar videos
-
10:32
axis capital conference 2019: biocon on their biosimilars business
-
1:54
ndtv profit exclusive | biocon biologics' kiran mazumdar shaw on viatris' acquisition
-
24:38
biocon's biosimilar blues
-
12:26
biocon's kiran shaw on biosimilars space
-
2:35
strong biosimilar growth powers biocon | trading hour | cnbc tv18
-
13:14
s.biomedics
-
8:56
4 saham ini bagi dividen 3 sampai 4 kali setahun!
-
3:40
biocon malaysia walkthrough
-
6:56
biocon biologics restructures deal with sii | nithya balasubramanian speaks on this & more
-
7:56
biocon launches biosimilar adalimumab in us market, drug used for arthritis, skin disorders
-
3:43
biocon set for new biosimilar launch
-
12:25
biocon biologics q3: biosimilars revenue up 54%, ebitda up 53% yoy
-
1:52
biocon initiates talks for potential stake sale in biosimilar arm & syngene | et now exclusive
-
1:27
boost for biocon. biosimilar trastuzumab accepted by ema
-
4:47
biocon biologics' shreehas tambe speaks on the firm's deal with japan's yoshindo | cnbc-tv18
-
0:35
biosimilars market size to hit usd 136,069.53 million by 2028
-
2:14
biocon biologics to acquire viatris global biosimilars assets for upto usd 3.335 bn in stock & cash
-
9:35
biocon and pfizer deal on insulin concluded, bloomberg utvi_1130am
-
23:22
press meet: biocon biologics to acquire viatris' biosimilars business for global leadership
-
14:18
exclusive | biocon biologics q4: serum will double investment to $300 mn
-
1:48
biocon-mylan launch semglee: a biosimilar insulin glargine in the us | kiran majumdar shaw to et now
-
5:01
biocon-1100 user training